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The growth factor/insulin-stimulated AGC kinases share
an activation mechanism based on three phosphorylation
sites. Of these, only the role of the activation loop phos-
phate in the kinase domain and the hydrophobic motif
(HM) phosphate in a C-terminal tail region are well
characterized. We investigated the role of the third, so-
called turn motif phosphate, also located in the tail, in the
AGC kinases PKB, S6K, RSK, MSK, PRK and PKC. We
report cooperative action of the HM phosphate and the
turn motif phosphate, because it binds a phosphoSer/
Thr-binding site above the glycine-rich loop within the
kinase domain, promoting zipper-like association of the
tail with the kinase domain, serving to stabilize the HM in
its kinase-activating binding site. We present a molecular
model for allosteric activation of AGC kinases by the turn
motif phosphate via HM-mediated stabilization of the aC
helix. In S6K and MSK, the turn motif phosphate thereby
also protects the HM from dephosphorylation. Our results
suggest that the mechanism described is a key feature in
activation of upto 26 human AGC kinases.
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Introduction
A signiﬁcant portion of growth factor/insulin signalling is
mediated by a functionally diverse, but structurally related
group of protein kinases that belong to the AGC kinase
family. The group, here called the growth factor-activated
AGC kinases, includes protein kinase B (PKBa-g or AKT1-3),
p70 ribosomal S6 kinase (S6K1,2), p90 ribosomal S6 kinase
(RSK1-4), mitogen- and stress-activated protein kinase
(MSK1,2) and several members of the protein kinase C
(PKC) family. These kinases regulate cellular division,
growth, survival, metabolism, motility and differentiation
and several of them are implicated in human disease. The
kinases function in partly distinct signalling pathways, such
as the phosphoinositide 3-kinase (PI3K) pathway (PKB and
S6K) (Kozma and Thomas, 2002), mitogen-activated protein
(MAP) kinase pathways (RSK and MSK) (Hauge and Frodin,
2006), in calcium/lipid signalling (PKC) (Parekh et al, 2000;
Newton, 2003), or in Rho GTPase signalling (PRK2) (Parekh
et al, 2000). The responsiveness to distinct upstream
pathways is partly due to distinct signalling modules ﬂanking
the kinase domain in the various kinases (Supplementary
Figure 1).
In addition to the divergent regulation, the growth factor-
activated AGC kinases share a common core mechanism of
activation, which is based on three conserved phosphoryla-
tion sites. Viewed simplistically, the ﬂanking signalling mod-
ules serve to induce proper phosphorylation of these
phosphorylation sites. The three sites are located in the
activation loop in the kinase domain, in the middle of a
tail/linker region C terminally to the kinase domain, and
within a hydrophobic motif (HM) at the end of the tail region,
respectively (Figure 1B and Supplementary Figure 1). The
various kinases thought to target the three phosphorylation
sites are indicated in Supplementary Figure 1.
Intense efforts have recently established the mechanism of
action of the HM and the activation loop phosphorylation
sites (Biondi et al, 2000; Frodin et al, 2002; Yang et al, 2002a,
2002b; Smith et al, 2004; Engel et al, 2006). Phosphorylation
of the HM triggers interaction of the phosphate with a
phosphate-binding site in the small lobe of the kinase do-
main, providing the ﬁnal binding energy required for the
aromatic residues of the HM to interact with and stabilize a
nearby hydrophobic pocket, which is disordered in the
inactive kinase. Stabilization of the so-called aC helix in
this pocket is thought to be of key importance, because this
helix contains key residues for regulation of phosphotransfer-
ase activity and it may aid in stabilizing the activation loop in
an optimal conformation. In RSK and S6K, the phosphorylated
HM additionally functions as a phosphorylation-dependent
docking site that recruits and activates the activation loop
kinase PDK1 (Frodin et al, 2000; Biondi et al, 2001). The
phosphate in the activation loop stimulates kinase activity by
binding to basic residues in loops within the active site,
which helps position catalytic residues (Knighton et al,
1991). Individual phosphorylation of the HM and the activa-
tion loop induces negligible and low-level activation, respec-
tively. However, in combination, the two phosphorylation
events synergistically stimulate kinase activity (Alessi et al,
1996; Frodin et al, 2002; Yang et al, 2002b). One mechanism
for this cooperativity is thought to derive from the ability of
both phosphates to promote interaction between the aC helix
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and the activation loop, leading to mutual stabilization of
these key regulatory structures and promotion of the active,
closed conformation of the kinase domain.
The phosphorylation site in the middle of the tail is the
most poorly characterized of the three conserved sites, yet its
mutation signiﬁcantly reduces kinase activity and in some
AGC kinases also HM phosphorylation (Moser et al, 1997;
Bellacosa et al, 1998; Weng et al, 1998; Parekh et al, 2000;
Newton, 2003; Matsuzaki et al, 2004; McCoy et al, 2004). In
RSK and MSK, the site is phosphorylated by extracellular
signal-regulated kinase (ERK) and p38 or ERK, respectively,
during activation (Dalby et al, 1998; McCoy et al, 2004). In
S6K, the site may be phosphorylated by mTOR and displays
high basal phosphorylation, which is increased twofold in
response to growth factor/insulin (Saitoh et al, 2002). In PKB,
the site is constitutively phosphorylated by an unknown
kinase (Alessi et al, 1996). In PKCs, the site is thought to
be autophosphorylated during maturation to the latent cata-
lytically competent conformation (Parekh et al, 2000;
Newton, 2003).
The mechanism of action of the phosphorylation site in the
middle of the tail is elusive. The AGC protein kinase A (PKA)
also contains a phosphorylation site in the middle of its tail
region, known as the ‘turn motif’ site, because the phosphate
binds nearby residues within the tail and thereby stabilizes a
turn in the tail. It has been widely assumed that the tail
phosphate in the growth factor-activated AGC kinases per-
forms the same function. Consequently, the site is also
known as the turn motif in these kinases and has been
aligned with the turn motif of PKA (Yang et al, 2002b;
Newton, 2003; Roux and Blenis, 2004).
Here, we report the mechanism(s) whereby the tail phos-
phorylation site activates PKBa, S6K1, RSK2, MSK1, PRK2
and PKCz, which represent six of the seven families of growth
factor-activated AGC kinases. We report that this phosphor-
ylation site is not equivalent to the turn motif site of PKA, but
rather corresponds to Glu333 of PKA. In the growth factor-
activated AGC kinases, the tail phosphate binds a
phosphoSer/Thr-binding site in the kinase domain near the
hydrophobic pocket, serving to deliver the HM to its binding
site in a zipper-like manner. Our results suggest that the tail
phosphate thereby synergistically enhances kinase activation
via HM-mediated stabilization of the aC helix and, in a subset
of the kinases, also controls the phosphorylation state of the
HM. On the basis of these ﬁndings, it could be considered
referring to the tail site in growth factor-activated AGC
kinases as the Z (zipper) site instead of the turn motif site.
Our results suggest that the overall mechanism described
is a key feature in the activation of up to 26 human AGC
kinases and has been widely conserved during evolution.
Results
A potential binding site for the tail phosphoSer/Thr is
widely conserved in the catalytic domain of AGC
kinases
PKBb has been crystallized in an active conformation show-
ing the HM bound to the hydrophobic pocket (Yang et al,
2002a). However a large portion of the tail region, including
the tail phosphorylation site (T451), was not visible in the
structure. The visible tail region ends with a short helix near
the small lobe of the kinase domain.
Our initial modelling analysis did not support the possibi-
lity of a binding site for phosphoT451 within the tail region.
We therefore analysed the small lobe of PKB for binding sites
for phosphoT451 using the programs GRASP and GRID.
Among various potential sites, we focused on the most
interesting site, located above the ATP-binding, glycine-rich
loop and formed by four basic residues, K160, K165, R184
and R224 (hereafter referred to as basic residues 1–4) of
which the ﬁrst two are part of the glycine-rich loop. Ab initio
modelling of the noncrystallized region of the tail suggested
that the phosphate of T451 might be located in the middle of
this basic cluster. The location appeared energetically favour-
able, because the phosphate remained in the site during
dynamics simulations on the model, constantly interacting
with 2 or 3 of the basic residues that differed over time
(Figure 1A). The four basic residues are conserved in all 23
members of the PKB, S6K, RSK, MSK, PRK and PKC families
(Figure 1C and Supplementary Figure 2). They are also
conserved in the three members of the SGK family of growth
factor-activated AGC kinases, which have a tail phosphoryla-
tion site (Kobayashi et al, 1999), required for full kinase
activity (CJ Jensen and M Frodin, unpublished observation).
Finally, the tail site and the basic residues are co-conserved
during evolution as illustrated by S6K orthologues from
Drosophila melanogaster, Caenorhabditis elegans, Arabidopsis
thaliana and Saccharomyces pombe (Supplementary Figure
2). Modelling of S6K1 and RSK2 supported the existence
of a phosphate-binding site homologous to that of PKBb
(Supplementary Figure 3). The basic residues are poorly
conserved in AGC kinases not thought to contain a tail
phosphorylation site (PDK1, ROCK, MRCK, LATS and
DMPK, Figure 1C).
Thus, modelling and sequence conservation suggested that
in the growth factor-activated AGC kinases, the tail
phosphoSer/Thr interacts with a phosphate-binding site
within the kinase domain, implying a different role of this
phosphorylation site from that of the turn motif site in PKA.
The functional characterization presented below suggests
that the tail phosphate promotes zipper-like binding of the
tail and HM to the kinase domain, aimed at controlling
activation of the kinases by the HM.
Role of the tail site in phosphorylation and activation
of AGC kinases in vivo
We ﬁrst characterized further the importance of the tail site in
the growth factor-activated AGC kinases. PKBa, S6K1, RSK2
and MSK1 were puriﬁed from transiently transfected COS7
cells exposed to an appropriate stimulus. PRK2, including the
truncated mutant used here, PRK2D1500, was active in non-
stimulated COS7 cells and was therefore puriﬁed from non-
treated cells.
Immunoblotting with phosphospeciﬁc antibodies showed
that the tail site was constitutively phosphorylated in PKBa,
PRK2 and S6K1 (sometimes a twofold induction was ob-
served in S6K1, Supplementary Figure 5A) and strongly in-
duced in RSK2 and MSK1 following stimulation (Figure 2).
Mutation of the tail site to Ala reduced activation fromE60%
in PKBa toE98% in S6K1 (Figure 2). Furthermore, in S6K1,
MSK1 and RSK2, mutation of the tail site reduced phosphor-
ylation of the HM with moderate to profound effects. In
PKBa, mutation of the tail site modestly enhanced phospho-
rylation of the HM and the activation loop. Mutation of the
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tail site to phosphate-mimicking Glu could substitute for
phosphorylation in PKBa and RSK2, partially in MSK1, but
not in PRK2 (Supplementary Figure 4), similar to ﬁndings
with S6K1 (Moser et al, 1997). These results further establish
the importance of the tail site in PKB, S6K, RSK and MSK and
report its role in the PRK family (and in PKCz, Figure 6) for
the ﬁrst time.
The predicted binding site for the tail phosphate is
essential for normal activation and phosphorylation
of AGC kinases in vivo
We next mutated the predicted binding site for the tail
phosphate by introducing amino acids that are present at
the corresponding positions in AGC kinases without a tail
site, assuming that such mutations would not compromise
tertiary structure. The assumption was supported by normal
expression of nearly all mutants. Analysis of 76 point mutants
suggested that the predicted binding site is functional in all
growth factor-activated AGC kinases and identiﬁed the most
important individual or combinations of basic residues in the
various AGC kinase subfamilies.
In PKBa, quadruple mutation of the four basic residues (as
in PKBa-K158T/K163S/K182S/R222N), reduced kinase activ-
ity by E40% (Fig 3A), comparable to the E60% reduction
resulting from mutation of the tail site T450 (Figure 2).
Moreover, phosphorylation of T450 was considerably re-
duced in PKBa-K158T/K163S/K182S/R222N, suggesting
that the binding of phosphoT450 to the basic residues
protects it from dephosphorylation. The ﬁnding that PKBa-
K158T/K163S/K182S/R222N had somewhat higher activity
than PKBa-T450A likely results from residual phosphoryla-
tion at T450 in the former mutant. The residual phosphate
may interact with the introduced Thr, Ser and Asn residues
and induce a small degree of activation, as these amino acids
can bind phosphoSer/Thr, although with lower afﬁnity than
Lys and Arg.
Surprisingly, single to triple mutation of the basic residues
in PKBa resulted in signiﬁcantly increased basal and insulin-
stimulated kinase activity, which apparently resulted from
increased phosphorylation of the HM and the activation loop
(Figure 3A). These mutations also increased the biological
activity of PKB, because NIH 3T3 cells virally transduced
with PKBa-K163S or PKBa-K182S showed a small, but sig-
niﬁcant increase in colony formation in sparsely seeded
cultures, as compared to cells transduced with wild-type
(wt) PKBa (C Hauge and M Frodin, unpublished observa-
tion).
In S6K1, mutation of basic residue 4 reduced kinase
activity by E85% (Figure 3A), comparable to the E98%
reduction caused by mutation of the tail site S371 (Figure 2).
Furthermore, mutation of basic residue 4 profoundly reduced
phosphorylation in the HM and moderately in the activation
loop, similar to the effects obtained by mutation of the tail
site. Mutation of basic residue 1 reduced kinase activity and
HM phosphorylation by E60% (Supplementary Figure 5A).
In RSK2, individual mutation of basic residues 1–4 had
negligible effect, but mutation of all four residues reduced
kinase activity by E40%, comparable to the E60% reduc-
tion caused by mutation of the tail site S369, and slightly
reduced HM phosphorylation. In MSK1, double mutation of
basic residues 2 and 4 reduced kinase activity to almost the
same low level as that obtained after mutation of the tail site
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Figure 1 Molecular modelling suggests a widely conserved binding
site for the tail/linker phosphoSer/Thr within the catalytic domain
of AGC kinases. (A) Model of active PKBb shown as a ribbon
representation with side chains of selected residues. The kinase
domain is shown in green and the tail/linker in red. Phosphate
groups are shown in yellow. K/R residues predicted to bind the
phosphate of phosphoT451 are shown in blue. Other phosphate-
binding residues are in cyan. The HM, glycine-rich loop and ATP
analogue are shown in magenta, orange and white, respectively.
Partial sequence alignment of the tail/linker (B) and predicted
binding site for the tail/linker phosphate (C) of AGC kinases.
(B, C) Phosphorylation sites/phosphate-mimicking residues are
shown in red. The aromatic residues that deﬁne the HM are
underlined. Basic residues predicted to bind the tail/linker
phosphoSer/Thr are shown in blue and labelled 1–4. Sequences
are human except S6K1 (rat, p70 isoform) and RSK2 (mouse).
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Figure 2 Role of the tail phosphorylation site in activation and phosphorylation of AGC kinases in vivo. COS7 cells were transfected with
plasmid expressing haemagglutinin (HA)- or glutathione S-transferase (GST)-tagged wt or mutant kinase. After 16 h and a ﬁnal 4 h serum-
starvation period, cells were exposed to 1mM insulin for 10min (PKBa), to 20nM EGF for 30min (S6K1) or 15min (RSK2), to 10 mg/ml
anisomycin for 40min (MSK1) or left in serum-containing medium (PRK2D1500) and then lysed. The kinases were precipitated from aliquots of
the cell lysates with antibody to the HA tag or with glutathione beads. The precipitates were subjected to kinase assay, to immunoblotting with
the indicated phosphorylation site-speciﬁc Ab or anti-HA Ab or stained for protein. Experiments were repeated at least three times and activity
data (expressed as percent) are means7s.d.
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Figure 3 The tail phosphate-binding site is essential for normal activation and phosphorylation of AGC kinases in vivo. The activity and
phosphorylation state of wt and mutant AGC kinases expressed in COS7 cells (A, C) or S2 cells (B) were analysed as described in Figure 2,
except that Drosophila S6K was activated by exposure of cells to 1mM insulin and 10 mM pervanadate for 15min. Experiments were repeated at
least three times and activity data (expressed as percentage) are means7s.d.
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S360. The double mutation also signiﬁcantly reduced phos-
phorylation of the HM, as did mutation of the tail site. In
PRK2, individual mutation of basic residue 2 (or 1 or 3,
Supplementary Figure 5C), reduced kinase activity to simi-
larly low levels as that obtained by mutation of the tail site
T958. Mutation of the basic residues caused a profound
reduction in phosphorylation of T958, suggesting that the
binding of phosphoT958 to these residues protects it from
dephosphorylation. In the various kinases, the effects of
mutating the tail site and the critical basic residues were
not additive (Supplementary Figure 5B and data not shown),
indicating that the tail phosphate and its predicted binding
site regulate kinase activity by the same mechanism.
The role of the tail phosphate appears highly conserved
during evolution, because mutation of the tail site S380 and
basic residue 4 (K153) abolished kinase activity and HM
phosphorylation of Drosophila S6K expressed in Drosophila
S2 cells (Figure 3B).
Because mutation of the tail phosphate-binding site de-
creased the phosphorylation of HM in S6K1 and MSK1, it
could not be determined whether the site affected kinase
activity by a mechanism other than regulation of HM depho-
sphorylation. To render the HM insensitive to phosphatases,
we generated mutants with Glu in the HM phosphorylation
site (S6K1-T389E and MSK1-S376E). S6K1-T389E possessed
higher activity than wt S6K1 (Figure 3C), in accordance with
previous ﬁndings (Weng et al, 1998). More importantly,
mutation of basic residue 1 or 4 in S6K1-T389E reduced
kinase activity to the same extent as did these mutations in
wt S6K1 without affecting the phosphorylation state
(Figure 3C and data not shown). Similar results were ob-
tained with MSK1-S376E (data not shown). Thus, the tail
phosphate-binding site can activate S6K1 and MSK1 by a
mechanism distinct from the one protecting the HM from
dephosphorylation.
In PKBa with Glu at the HM phosphorylation site (PKBa-
S473E), the quadruple mutation (K158T/K163S/K182S/
R222N) and the K163S mutation of the tail phosphate-binding
site had the same effects as in wt PKBa (Figure 3C). This
agrees with the results obtained with wt PKBa that severe
disruption of the interaction between the tail phosphate and
its binding site precludes full kinase activity and that high
levels of phosphorylation in the activation loop and Glu in
the HM cannot compensate for the disrupted interaction. In
PKBa-S473E with deletion of the PH domain (DPH-PKBa-
S473E), the K163S mutation did not increase phosphorylation
or kinase activity of PKBa (Supplementary Figure 5D),
further suggesting that this mutation stimulates PKBa activity
by inducing hyperphosphorylation, which may occur at the
plasma membrane. In DPH-PKBa-S473E, mutation of the tail
site had less effect on kinase activity compared to full-length
PKBa (Supplementary Figure 5D), possibly because DPH-
PKBa-S473E was less phosphorylated at the tail site
(Supplementary Figure 5E), which suggests that membrane
localization of PKBa promotes phosphorylation of the tail
site. However, these experiments should be interpreted with
caution, because deletion of the PH domain likely alters the
conformation of PKB.
We conclude that the tail phosphate interacts with a
binding site widely conserved among growth factor-activated
AGC kinases. We propose that the tail phosphate thereby
functions as a molecular zipper that helps deliver the HM to
its binding site and stabilize it there, which has two con-
sequences. First, in all of the kinases this directly stimulates
kinase activity, presumably by stabilization of the active
kinase conformation. Secondly, in a subset of the kinases
this controls the phosphorylation state of the HM, presum-
ably by restricting its exposure to phosphatases and kinases.
Although a functional tail phosphate-binding site is con-
served in all of the kinases studied, the key basic residues
involved in forming the site varies somewhat among the
different AGC kinase families.
Further evidence of the tail phosphate-binding site
If the tail phosphate and the basic residues are indeed within
interaction distance, it might be possible to engineer a Zn2þ -
binding site by replacing the tail site Ser/Thr and the basic
residues with histidine residues. A Zn2þ -binding site may be
detected by Zn2þ -dependent modulation of enzymatic func-
tion, most often inhibition due to distortion of protein
structure. Zn2þ up to 3.3 mM had no effect on the activity
of wt PRK2 or PRK2 with His in the tail site (PRK2-T958H)
(Figure 4A). By contrast, PRK2 with His in place of basic
residues 2 and 3 (PRK2-K670H/K689H) was inhibited by
Zn2þ at 3.3 mM, but not at lower concentrations. Thus, the
close proximity of basic residues 2–4 (wt PRK2 has His at the
position of basic residue 4) allowed engineering of a Zn2þ -
binding site, which caused Zn2þ -dependent inhibition of
kinase activity, possibly due to distortion of the glycine-rich
loop. More importantly, introduction of His in the tail site
(T958H) of PRK2-K670H/K689H, generated a Zn2þ -binding
site with increased afﬁnity, as evidenced by more profound
inhibition at 3.3 mM and detectable inhibition already at
0.5 mM Zn2þ . Similar results were obtained after Zn2þ site
engineering in PKBa (data not shown).
Furthermore, if the tail site Ser/Thr and the basic residues
are within interaction distance, mutation of the tail site Ser/
Thr to Arg might inhibit kinase activity to a higher extent
than an Ala mutation due to electrostatic repulsion of the tail.
In MSK1, an S360R mutation indeed inhibited kinase activity
to a higher extent (E90%, Figure 4B) than an S360A muta-
tion (E80%, Figure 2). MSK1-K62E/K84S/K126N, which has
an acidic residue in place of basic residue 2 and neutral
charge in place of basic residues 3 and 4 had E15% activity
compared to wt MSK1. Strikingly, in this mutant, introduc-
tion of the S360R mutation was not inhibitory, but rather
increased kinase activity toE40% of that of wt MSK1. In this
charge-reversal mutant, R360 presumably binds E62 intro-
duced in place of basic residue 2 and thereby partially rescues
kinase activity.
In conclusion, these experiments provide evidence that the
tail phosphate and the basic cluster are within interaction
distance in the active AGC kinase conformation.
The tail phosphate synergistically enhances AGC kinase
activation by the phosphorylated HM, dependent on the
tail phosphate-binding site
We established an in vitro reconstitution assay that could test
a direct activation of the AGC kinase domain by the tail
phosphate and characterize its cooperation with the HM and
activation loop phosphates. The deletion mutant S6K11364,
which contains the kinase domain, but lacks the region of the
tail containing the tail site and the HM as well as the C-
terminal autoinhibitory domain, was expressed and puriﬁed
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from COS7 cells, either nonphosphorylated or phospho-
rylated at T221 in the activation loop, achieved by co-
expression with PDK1. Puriﬁed S6K11364 was then incubated
with synthetic peptides of the S6K1 tail (residues
366–395: QTPVDS371PDDSTLSESANQVFLGFT389YVAPSV),
which were either nonphosphorylated (S371/T389), phos-
phorylated at the tail site (pS371/T389), phosphorylated in
the HM (S371/pT389) or phosphorylated at both sites
(pS371/pT389). Subsequently, the kinase activity of
S6K11364 was determined.
S371/T389 or pS371/T389 tail peptides did not stimulate
the kinase activity of Thr221-phosphorylated S6K11364,
whereas S371/pT389 peptide induced a ﬁve- to sevenfold
stimulation of kinase activity at 190 mM (Figure 5A). More
importantly, pS371/pT389 peptide induced a 16- to 22-fold
stimulation of kinase activity at 190 mM. These experiments
revealed that the tail phosphate synergistically enhances
S6K1 activation by the HM phosphate, whereas having no
effect on its own. In similar experiments with a truncated
PKBb kinase domain, the tail phosphate also enhanced the
ability of the HM to stimulate kinase activity (Supplementary
Figure 6B).
We next investigated the role of the tail phosphate-binding
site. The basic residue 4 mutant S6K11364 K144N was
activated normally by S371/pT389 peptide (Figure 5B, com-
pare bars 3 and 7), but could not be hyperactivated by pS371/
pT389 (compare bars 4 and 8), indicating that the tail
phosphate-binding site mediates the kinase-activating effect
of the tail phosphate. As a control, S6K11364 K144N was
phosphorylated and activated normally by PDK1 (compare
bars 2 and 6 in Figure 5B, Supplementary Figure 6A),
indicating that the K144N mutation did not compromise the
tertiary structure of S6K1, but selectively disrupted the tail
phosphate-binding site. As another control, PDK1, which
lacks a tail phosphate-binding site (Figure 1C) but contains
a pHM-binding site (Biondi et al, 2002; Frodin et al, 2002),
was activated to the same extent by S371/pT389 and pS371/
pT389 (Supplementary Figure 6C).
Surface plasmon resonance measurements revealed that
the K144N mutation decreased the binding of S6K11365 to
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pS371/pT389 peptide by E50% (Figure 5C). Similarly, the
K144N mutation decreased the binding of S6K11365 to
pS371/T389 peptide by about 40%, whereas the K144N
mutation had no effect on the binding of S6K11365 to S371/
pT389 peptide (data not shown). No speciﬁc binding of
S6K11365 or S6K11365 K144N to S371/T389 peptide could
be detected. Binding constants for these interactions could
not be determined using the BiaCore instrument, because the
afﬁnities were too low for kinetic analysis, in accordance with
the AC50 value of E60 mM for pS371/pT389 towards
S6K11365 (Figure 5A). As a control, PDK1 bound equally
well to S371/pT389 and pS371/pT389 (Supplementary Figure
6D). We conclude that the binding contribution of pS371 in
these experiments result from interaction with the tail phos-
phate-binding site.
These results support the model that the interaction be-
tween the tail phosphate and its binding site promotes the
binding of the tail to the kinase domain and thereby the tail
phosphate synergistically enhances kinase activation by the
phosphorylated HM.
The tail phosphate promotes a compact AGC kinase
conformation and protects the tail phosphate-binding
site and aC helix from solvent exposure as revealed by
amide hydrogen (1H/2H) exchange and mass
spectrometry
Proteins analysed by hydrogen (1H/2H) exchange and mass
spectrometry (HXMS) are incubated in D2O and the mass
increase resulting from isotopic exchange of backbone amide
protons (one per residue, except for proline) for solvent
deuterons is measured by mass spectrometry. Differences in
hydrogen-exchange rates between protein samples reﬂect
differences in solvent exposure due to conformational change
and/or protein–protein interaction. Sites of conformational
change/interaction are revealed as regions with increased
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protection in analyses of peptic digests of the labelled pro-
teins (local HXMS).
Addition of S371/pT389 and pS371/pT389 peptide to
S6K11365, resulted in E10 and E25 fewer deuterons incor-
porated, respectively, in S6K11365 at early time points of
analysis, as compared to no peptide added (Figure 6A). The
nonphosphorylated S371/T389 peptide had no effect, demon-
strating that nonspeciﬁc peptide binding to S6K11365 did not
contribute to the surface protection.
We next investigated the effect of the tail phosphate on
deuteron uptake in a full-length AGC kinase. For this analysis
we chose PKCz, because only this kinase, among the ones
tested, was found to be stoichiometrically phosphorylated at
all the regulatory phosphorylation sites, which is critical for
HXMS analysis. First, we demonstrated that the tail site T560
is essential for full PKCz activity and identiﬁed basic residues
2 and 4 (K265 and K284) as key residues in the tail phos-
phate-binding site (Figure 6B). Second, we found that muta-
tion of the tail site and its binding site greatly increased global
deuteron uptake by PKCz and to exactly the same extent
(Figure 6C). At early time points of analysis, the tail phos-
phate protected E60 residues. Finally, we sought to identify
speciﬁc regions in PKCz protected by the tail phosphate by
local HXMS analysis. Strikingly, peptide (a), corresponding to
the regulatory aC helix was dramatically protected by the tail
phosphate (Figure 6D). Moreover, protection was observed in
peptide (b), but not in the overlapping peptide (c). This
means that the 2 or 3 protected residues in peptide (b) are
to be found in the sequence AKVLL, which encompasses
a C-terminal residue of the glycine-rich loop and basic residue
2 (underlined). Protection was also observed in peptide (d),
encompassing part of the aG helix, consistent with the
ﬁnding that this helix is disturbed in PKB structures with a
disordered aC helix. Slight protection was observed in pep-
tide (e) corresponding to the start of the tail region. No
protection was observed in peptide (f), located in a region
of the large lobe not predicted to be affected by the tail
phosphate or in peptide (g) located between the tail site and
the HM, in agreement with the solvent exposed and ﬂexible
nature of this segment, as revealed by its near-complete
deuteron uptake. For technical reasons, the sequence cover-
age of PKCz was not complete and we could not therefore
perform a full analysis of the effect of the tail phosphate on
local HX.
The local HXMS analysis provides strong evidence that the
tail phosphate interacts with basic residue 2 in the binding
site and that it promotes a dramatic stabilization of the
regulatory aC helix of the hydrophobic pocket. Moreover,
the large extent of protection revealed by global HXMS
strongly suggests that the tail phosphate promotes a signiﬁ-
cant allosteric change to a more compact conformation,
which most likely corresponds to the closed, active AGC
kinase conformation.
The tail site is not related to the turn motif site in PKA
We noticed that in active, but not inactive structures of PKA
(1ATP/1YDR/1FMO/1L3R and 1CTP/1CMK, respectively),
R56, which aligns with basic residue 2, binds E333 in the
PKA tail. Moreover, E333 holds a similar position as the tail
phosphate in our models (Figure 7A). Mutation of R56 or
E333/E334 profoundly reduced autophosphorylation in the
activation loop and catalytic activity of PKA (Figure 7B).
Individual mutation of E333 had little effect, suggesting
compensatory action by E332, which is in close proximity
to R56 in active PKA structures. Similar compensatory action
has been reported upon mutation of the tail site in PKCbII
(Newton, 2001). Our results with PKA suggest that the E333/
R56 interaction evolved from the tail phosphate/basic residue
1–4 interaction or vice versa, implying that the tail site should
be aligned with E333, rather than with the turn motif site
(Figure 7D). In such a revised alignment, the PKA turn motif
site aligns well with S375 in RSK2, recently identiﬁed as a site
of phosphorylation (Ballif et al, 2005). Interestingly, mutation
of S375 to Ala reduced EGF-stimulated RSK2 activity by
E20%, whereas a phosphate-mimicking Glu mutation did
not (Figure 7C). The inhibitory effects of the S375A and the
tail site S369A mutations were additive, indicating that the
two phosphorylation sites stimulate RSK2 activity by distinct
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the legend of Figure 1A, except that residues known/thought to
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mechanisms. In agreement with this conclusion, modelling
and dynamics simulations suggested that phosphoS375 does
not interact with the tail phosphate-binding site but may bind
neighbouring polar residues within the tail, thereby resem-
bling the turn motif phosphate in PKA (Figure 7A).
We conclude that the tail site and the turn motif site are
nonrelated rather than being the same site which adopts two
distinct conformations in growth factor-activated AGC ki-
nases and PKA, respectively. Thus, AGC kinases may contain
either or both sites, and in PKA, the tail site consists of a
phosphate-mimicking Glu. On the basis of these present
ﬁndings, we propose to refer to the tail site in growth
factor-activated AGC kinases as the Z (zipper) site instead
of the turn motif site.
Discussion
The molecular mechanism whereby the tail phosphorylation
site stimulates the activity of the growth factor-activated AGC
kinases has been the last unresolved issue in their common
activation mechanism. The data presented here support the
following model: the tail phosphate interacts with a phos-
phate-binding site in the small lobe of the kinase domain,
located on top of the ATP-binding, glycine-rich loop. The tail
phosphate-binding site thereby provides an anchoring point
for the tail, which increases the local concentration of the HM
in the immediate vicinity of the binding site through which
the HM stimulates kinase activity. This increase in local
concentration is likely to be important, because the afﬁnity
of the phosphorylated HM for its binding site is very low,
with estimated Kd values ranging from 30 to 600 mM among
various AGC kinases (Frodin et al, 2002; Yang et al, 2002b;
this study). By increasing the local concentration, the tail
phosphate-binding site enhances the ability of the phos-
phorylated HM to interact with the hydrophobic pocket.
Our model further proposes that the tail phosphate-binding
site thereby allosterically affects the aC helix and protects the
HM from dephosphorylation.
The tail phosphate-binding site thus promotes kinase
activity by at least two mechanisms. In the ﬁrst mechanism,
which likely operates in all of the growth factor-activated
AGC kinases, the tail phosphate-binding site allosterically
supports the reordering of the HM-binding pocket, including
the aC helix. Stabilization of the aC helix is thought to be of
key importance in activation of AGC kinases. In the ordered
aC helix, a conserved Glu stabilizes a conserved Lys, which
positions the a- and b-phosphates of ATP, whereas other
residues are thought to stabilize the activation loop, which
likely constitutes a mechanism for cooperation between the
HM and activation loop phosphates in stimulation of kinase
activity. It is therefore a highlight of this study that local
HXMS analysis showed dramatic stabilization of the aC helix
by the tail phosphate. We estimate that the tail phosphate
protects E50% of the residues in the aC helix, providing
strong evidence for our model that the tail phosphate func-
tions to aid the HM to bind and reorder the hydrophobic
pocket. The results also provide the ﬁrst in-solution evidence
of stabilization of the aC helix during AGC kinase activation.
Previously, the disorder-to-order transition of the aC helix
was supported mainly by comparison of crystal structures of
inactive and active PKB (Yang et al, 2002a, 2002b). Global
HXMS analysis suggested that E60 residues were protected
by the tail phosphate in PKCz, a number exceeding the
residues in the tail phosphate-binding sites and the aC
helix. This suggests that the tail phosphate promotes a
signiﬁcant allosteric change, which we assume corresponds
to stabilization also of the aB helix, another component of the
HM-binding pocket and of the activation loop, leading to
stabilization of the entire kinase domain in the closed, active
conformation.
In the second mechanism, the tail phosphate-binding site
stimulates kinase activity by increasing the phosphorylation
level in the HM. This mechanism operates only in a subset of
the AGC kinases such as S6K, MSK and to a slight extend RSK
(this study), and likely also in several PKCs, where mutation
of the tail site decreases HM phosphorylation (Parekh et al,
2000; Newton, 2003). The second mechanism is most likely
linked to the ﬁrst mechanism, because interaction of the
phosphorylated HM with its binding site presumably renders
the phosphate less accessible to phosphatases due to its
binding to several charged/polar residues. The reason that
the second mechanism may operate only in some AGC
kinases may partly be due to the possibility that the HM in
the various AGC kinases is targeted by distinct phosphatases
with varying efﬁciency.
Basic residues 1 and 2 are located at the base of the
glycine-rich loop that positions the g-phosphate of ATP for
phosphotransfer. In our HXMS analysis, the tail phosphate
affected the ﬂexibility of the segment AKVLL, which encom-
passes part of the glycine-rich loop and basic residue 2. It
would be interesting to investigate whether the tail phosphate
may promote kinase activity by modulating the position of
the glycine-rich loop via basic residue 2 in addition to the two
mechanisms described above.
Our data suggest that the tail phosphate-binding site is
composed of four basic residues. The indispensability of
individual basic residues varied among the kinases. For
instance, in S6K1 and PRK2, individual mutation of basic
residues 4 and 1–3, respectively, inhibited kinase activity by
485%, whereas in PKBa and RSK2, all four basic residues
must be mutated to achieve substantial inhibition. In some
kinases, we observed that individual mutation of a particular
basic residue had negligible effect, but the same mutation
enhanced the inhibitory effect of other basic residue muta-
tions (data not shown). However, caution needs to be taken
regarding conclusions on the exact contribution/importance
of speciﬁc basic residues, because we introduced semicon-
servative substitutions like Ser, Thr or Asn with some phos-
phate-binding ability. Nevertheless, taken together, our
results suggest that the tail phosphate may bind several
distinct combinations of basic residues, which may change
dynamically over time. This possibility is supported by the
open appearance of the tail phosphate-binding site in the
PKBb crystal structure and by our molecular dynamics simu-
lations. Similar dynamic interaction modes may also exist for
the PKA turn motif phosphate, perhaps due to the ﬂexible
nature of the PKA tail region (Johnson et al, 2001). Thus, the
turn motif phosphate binds R336, N340 and K342 in the
structure 1FMO, N340 and K342 in 1ATP, and none of these
residues in 1BKK. In the growth factor-activated AGC kinases,
the four basic residues might perform partly distinct roles. For
instance, basic residue 1 may function mainly to attract the
tail phosphate, followed by docking of the tail phosphate to
the more deeply positioned basic residues 2–4. Basic residues
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3 and 4 are located in the nonﬂexible b-strands 3 and 5,
respectively. Binding to these residues may ﬁx the tail phos-
phate, allowing it to affect the position of the nonrigid
glycine-rich loop via interaction with basic residue 2.
Recently, a crystal structure of the PKCi kinase domain was
reported (Messerschmidt et al, 2005). In this structure, the
tail phosphate binds basic residues 3 and 4, in agreement
with our study. Unlike our model, the authors speculated that
the phosphate may function (1) to stabilize the kinase
domain, referring to the destabilizing effect of mutation of
the turn motif site of PKA and the kinase-inactivating effect of
mutation of the tail site in PKC, (2) to push the tail out of the
active site or (3) to regulate the interaction of the kinase
domain with the ﬂanking signalling modules in PKC. The role
of the tail phosphate and its interactions were not investi-
gated. The side chain of the basic residue 2 Lys was not
visible in the structure, but we noted that its backbone is
located immediately beneath the tail phosphate, allowing
binding of the side chain to the tail phosphate. We therefore
mutated the tail site T555 and the basic residues 2–4
and observed a E25% reduction of kinase activity
(Supplementary Figure 7). The mutational analysis thus
revealed that the interaction is required for full PKCi activa-
tion, but also showed that the tail phosphate is less important
for PKCi than for other AGC kinases that we have analysed.
This study provides the ﬁrst characterization of the co-
operation between all three conserved phosphates in stimula-
tion of AGC kinase activity by using an in vitro reconstitution
assay based on long tail peptides. Our data showed that the
three phosphates act in a hierarchal manner: the tail phos-
phate has no activating effect alone or together with the
activation loop phosphate. However, the tail phosphate sy-
nergistically enhances the ability of the HM phosphate to
stimulate kinase activity in cooperation with the activation
loop phosphate. Global HXMS analysis in this system sug-
gested that the tail phosphate promoted a signiﬁcant allos-
teric change, which we assume represents HM-mediated
transition to the closed, active AGC kinase conformation.
Our model and data thus imply that the activating conforma-
tional change induced by binding of the HM to the hydro-
phobic pocket is triggered not only by HM phosphorylation,
as previously suggested, but is also regulated by the dual
phosphorylation events in the tail site and the HM, working
in a cooperative manner.
These results together with previous studies underscore
the extensive cooperation of the three conserved phosphor-
ylation sites with respect to shifting the equilibrium of the
AGC kinase catalytic domain from the inactive, open con-
formation towards the active, closed conformation during
stimulus-induced activation. This cooperativity is likely also
an important determinant during inactivation. In many of the
kinases, the phosphorylation sites are rapidly dephosphory-
lated upon cessation of the activating stimulus. In this
process, dephosphorylation at one site may greatly decrease
the ability of the remaining phosphates to support the active,
closed and more phosphatase-resistant conformation, result-
ing in accelerated dephosphorylation of the remaining phos-
phates and complete inactivation of the kinase.
Elevated PKB activity is essential for the progression of
many human cancers and may result from mutations in, for
example, PI3K or phosphatase and tensin homolog deleted on
chromosome 10 (PTEN). Recently, two point mutations in
PKB were identiﬁed in colorectal cancer (Parsons et al, 2005).
This study reports mutations in the tail phosphate-binding
site, which yielded a considerable degree of activation and
which stimulated cell growth (C Hauge and M Frodin,
unpublished observation). Activation appeared to result
from increased phosphorylation in the HM and the activation
loop. Presumably, the aberrantly exposed HM of PKB in these
mutants becomes hyperphosphorylated by the physiological
PKB HM kinase or by some other HM kinase. Profound
hyperphosphorylation of PKB was not observed after severe
disruption of zipper function such as in PKBa-T450A.
Conceivably, if the HM of PKB becomes excessively exposed,
phosphatase action counteracts kinase action. The increased
activation loop phosphorylation may be a consequence of the
increased HM phosphorylation, because the phosphorylated
HM is thought to promote the closed, and more phosphatase-
resistant conformation of the AGC kinase domain.
Alternatively, the abnormally exposed HM may increase
activation loop phosphorylation by recruitment of PDK1, as
HM phosphorylation may enhance phosphorylation of PKB
by PDK1 under certain conditions (Scheid et al, 2002).
Regardless of the mechanism, our results suggest that ele-
vated PKB activity in cancer cells may result from mutations
in the tail phosphate-binding site of PKB.
Our study suggests that the tail site and the turn motif site
are two distinct phosphorylation sites that should not be
aligned. Because it is problematic to use the designation ‘turn
motif’ for two distinct sites, we propose to refer to the tail site
as the Z (zipper) site, a name that reﬂects one major function
of this phosphorylation site according to the present ﬁndings.
In conclusion, this study provides important information
on the missing pieces in the core mechanism, whereby three
conserved phosphorylation sites stabilize the active confor-
mation of up to 26 human AGC kinases, which thus repre-
sents one of the most general activation mechanisms reported
in the human kinome.
Materials and methods
Procedures are described in Supplementary data.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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